FIP1L1 and atopic eczema: Recently, drugs like imatinib have shown some good response in patients with clonal mutations like FIP1L1-PDGFRA [11-13]. Likewise, the role of dupilumab in HIES, particularly with atopic dermatitis, has shown promise [13].